Non-structural protein 3 (NSP3)

Non-structural protein 3 (NSP3) is the largest and most complex protein encoded by the coronavirus genome, functioning as a critical multi-domain scaffold for the viral replicase-transcriptase complex (RTC). Its most therapeutically significant domain is the papain-like protease (PLpro), which is responsible for cleaving the viral polyprotein at three specific sites to release mature non-structural proteins essential for viral replication (UniProt P0DTD1, 2020). Beyond its proteolytic role, NSP3 acts as a deubiquitinating and de-ISGylating enzyme, removing ubiquitin and ISG15 from host cell proteins to effectively suppress the host's innate immune signaling, particularly the type I interferon response (PubMed: 32423130, 2020). This dual functionality makes it a vital factor for both the viral life cycle and the evasion of host defenses. Consequently, NSP3 is a high-priority target for antiviral drug development, with research focusing on small-molecule inhibitors that can block its catalytic site to arrest viral progression and restore host immune competence (PubMed: 32719591, 2020). Therapeutic strategies targeting NSP3 aim to provide both direct antiviral effects and a synergistic boost to the patient's natural immune response against Coronaviridae infections.

Other names

Papain-like proteasePLproNSP3 proteasep150Replicase polyprotein 1a

Inhibition of the papain-like protease (PLpro) catalytic activity within NSP3 to prevent viral polyprotein cleavage and block the suppression of the host's innate immune response.